Precigen, Inc. (PGEN)
NASDAQ·Healthcare·Biotechnology
$6.70
+1.21%
Mkt Cap $2.12B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (3 analysts)
$14.00
Range $14.00 – $14.00
Implied Upside
+109.1%
Consensus $14.00 vs current $6.70
NASDAQ·Healthcare·Biotechnology
$6.70
+1.21%
Mkt Cap $2.12B
Buy
4
Hold
0
Sell
0
Price Target (3 analysts)
$14.00
Range $14.00 – $14.00
+109.1%
Consensus $14.00 vs current $6.70